Authors:
Nichols, WG
Corey, L
Gooley, T
Drew, WL
Miner, R
Huang, ML
Davis, C
Boeckh, M
Citation: Wg. Nichols et al., Rising pp65 antigenemia during preemptive anticytomegalovinus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes, BLOOD, 97(4), 2001, pp. 867-874
Authors:
Landry, ML
Stanat, S
Biron, K
Brambilla, D
Britt, W
Jokela, J
Chou, SW
Drew, WL
Erice, A
Gilliam, B
Lurain, N
Manischewitz, J
Miner, R
Nokta, M
Reichelderfer, P
Spector, S
Weinberg, A
Yen-Lieberman, B
Crumpacker, C
Citation: Ml. Landry et al., A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates, ANTIM AG CH, 44(3), 2000, pp. 688-692
Authors:
O'Sullivan, CE
Drew, WL
McMullen, DJ
Miner, R
Lee, JY
Kaslow, RA
Lazar, JG
Saag, MS
Citation: Ce. O'Sullivan et al., Decrease of cytomegalovirus replication in human immunodeficiency virus infected-patients after treatment with highly active antiretroviral therapy, J INFEC DIS, 180(3), 1999, pp. 847-849
Authors:
Drew, WL
Stempien, MJ
Andrews, J
Shadman, A
Tan, SJ
Miner, R
Buhles, W
Citation: Wl. Drew et al., Cytomegalovirus (CMV) resistance in patients with CMV retinitis and AIDS treated with oral or intravenous ganciclovir, J INFEC DIS, 179(6), 1999, pp. 1352-1355
Authors:
Cherrington, JM
Fuller, MD
Lamy, PD
Miner, R
Lalezari, JP
Nuessle, S
Drew, WL
Citation: Jm. Cherrington et al., In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: Relationship to clinical outcome, J INFEC DIS, 178(6), 1998, pp. 1821-1825